Abstract:The application of metabolomics in translational research suffers from several technological bottlenecks, such as data reproducibility issues and the lack of standardization of sample profiling procedures. Here, we report an automated high-throughput metabolite array technology that can rapidly and quantitatively determine 324 metabolites including fatty acids, amino acids, organic acids, carbohydrates, and bile acids. Metabolite identification and quantification is achieved using the Targeted Metabolome Batch Quantification (TMBQ) software, the first cross-vendor data processing pipeline. A test of this metabolite array was performed by analyzing serum samples from patients with chronic liver disease (<i>N</i> = 1234). With high detection efficiency and sensitivity in serum, urine, feces, cell lysates, and liver tissue samples and suitable for different mass spectrometry systems, this metabolite array technology holds great potential for biomarker discovery and high throughput clinical testing. Additionally, data generated from such standardized procedures can be used to generate a clinical metabolomics database suitable for precision medicine in next-generation healthcare.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.analchem.0c04686?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.analchem.0c04686</a>.MRM transitions of 3-NPH derivatized metabolites, linearity range, precision, and accuracy (Table S1) (<a class="ext-link" href="/doi/suppl/10.1021/acs.analchem.0c04686/suppl_file/ac0c04686_si_001.xlsx">XLSX</a>)UPLC-MS/MS instrument settings (Table S2). Clinical information on study subjects (Table S3). Stability of derivatized analytes in biological sample matrices stored under −80 °C (Table S4). Metabolites identified by TargetLynx (Table S5). Metabolites identified by TMBQ (Table S6). The relative differences of levels of metabolites (mean ± S.D.) identified by TMBQ and TargetLynx (Table S7). The Pearson correlation coefficients of the same metabolites quantified by TMBQ and TargetLynx (Table S8). Quantification results in normal human serum, urine, feces, mouse liver and HepG2 cell samples (Median ± SE) (Table S9). Detected metabolites in the control and liver disease patients (Table S10). Effect of the concentration and quantity of the 3-nitrophenylhydrazine on the chemical derivatization (Figure S1). Effect of the concentration and quantity of the EDC on the 3-nitrophenylhydrazine derivatization (Figure S2). Effect of reaction temperature on the 3-nitrophenylhydrazine derivatization of some selected metabolites (Figure S3). Effect of reaction time on the 3-nitrophenylhydrazine derivatization of some selected metabolites (Figure S4). Typical TIC chromatograms of all 320 metabolite standards (Figure S5). Typical EIC of organic acid standards (Figure S6). Typical EIC of carbohydrates (Figure S7). Typical EIC of bile acid standards (Figure S8). Typical EIC of fatty acid standards (Figure S9). Typical EIC of amino acids and nucleotides (Figure S10). Typical EIC of short chain fatty acids (Figure S11). Workflow and main features of TMBQ (Figure S12). Fragmentation pattern of butyric acid in ESI negative mode as an example (Figure S13). The real metabolite assay kit of the metabolite array used for the analysis of samples in this study (Figure S14). OPLS-DA scores plots of serum metabolite profiles of the controls and liver disease patients and Pie chart showing the chemical classification of the detected metabolites in liver disease patients (Figure S15). 3D scores plot of serum metabolite profiles of (A) HBV patients, fibrosis and cirrhosis patients, and (B) HCC and ICC patients (Figure S16) (<a class="ext-link" href="/doi/suppl/10.1021/acs.analchem.0c04686/suppl_file/ac0c04686_si_002.pdf">PDF</a>)This article has not yet been cited by other publications.

High-Coverage Strategy for Multi-Subcellular Metabolome Analysis Using Dansyl-Labeling-Based LC-MS/MS.

Single Cell Mass Spectrometry with a Robotic Micromanipulation System for Cell Metabolite Analysis

Dansylation Isotope Labeling Liquid Chromatography Mass Spectrometry for Parallel Profiling of Human Urinary and Fecal Submetabolomes.

High-coverage Quantitative Liver Metabolomics Using Perfused and Non-Perfused Liver Tissues.

Stepwise solid phase extraction integrated with chemical derivatization for all-in-one injection LC-MS/MS analysis of metabolome and lipidome

Controlling Preanalytical Process in High-Coverage Quantitative Metabolomics: Spot-Sample Collection for Mouse Urine and Fecal Metabolome Profiling.

Development of High-Performance Chemical Isotope Labeling LC-MS for Profiling the Human Fecal Metabolome.

Isotope labelled in suit derivatization-extraction integrated system for amine/phenol submetabolome analysis based on nanoconfinement effect: Application to lung cancer

Simultaneous 3-Nitrophenylhydrazine Derivatization Strategy of Carbonyl, Carboxyl and Phosphoryl Submetabolome for LC-MS/MS-Based Targeted Metabolomics with Improved Sensitivity and Coverage.

A systemic workflow for profiling metabolome and lipidome in tissue.

Absolute Quantification of Acylcarnitines Using Integrated Tmt-PP Derivatization-Based LC–MS/MS and Quantitative Analysis of Multi-Components by a Single Marker Strategy

Development of High-Performance Chemical Isotope Labeling LC-MS for Profiling the Carbonyl Submetabolome.

A convenient and efficient 4-(diethylamino)-butylamine-labeled polarity-response-homodispersed strategy for absolute quantification of carboxyl submetabolome: Monitoring the whole progressive course of hepatocellular carcinoma

Dansylhydrazine Isotope Labeling LC-MS for Comprehensive Carboxylic Acid Submetabolome Profiling

A Metabolite Array Technology for Precision Medicine

Metabolomic Coverage of Chemical-Group-Submetabolome Analysis: Group Classification and 4-Channel Chemical Isotope Labeling LC-MS.

Intracellular metabolic profiling of drug resistant cells by surface enhanced Raman scattering

Chemical Isotope Labeling LC-MS for High Coverage and Quantitative Profiling of the Hydroxyl Submetabolome in Metabolomics.

A Mass Spectrometry-based Label-free Quantitative Approach Coupled With Complex Proteome Functional Analysis

Profiling acidic metabolites by capillary electrophoresis‐mass spectrometry in low numbers of mammalian cells using a novel chemical derivatization approach

Ex vivo and in vivo stable isotope labelling of central carbon metabolism and related pathways with analysis by LC–MS/MS